Preservation of peritoneal morphology and function by pentoxifylline in a rat model of peritoneal dialysis: Molecular studies

Nephrology Dialysis Transplantation

Volumn 23, Issue 12, 2008, Pages 3831-3840

  Hung, Kuan Yu ^a   Huang, Jenq Wen ^a   Chiang, Chih Kang ^a,b   Tsai, Tun Jun ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Fibrosis; High glucose; Mesothelial cell; Pentoxifylline; TGF 1

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; COLLAGEN; CYTOKINE; GLUCOSE; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; PENTOXIFYLLINE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL FUNCTION; CELL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MESOTHELIUM CELL; NONHUMAN; PERITONEAL DIALYSIS; PERITONEAL FIBROSIS; PERITONEUM; PRIORITY JOURNAL; RAT; WISTAR RAT;

ANIMALS; BASE SEQUENCE; CELLS, CULTURED; COLLAGEN TYPE I; CYTOKINES; DIALYSIS SOLUTIONS; DISEASE MODELS, ANIMAL; DNA PRIMERS; EPITHELIAL CELLS; FIBROSIS; GENE EXPRESSION; GLUCOSE; HUMANS; MALE; MAP KINASE SIGNALING SYSTEM; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PENTOXIFYLLINE; PERITONEAL DIALYSIS; PERITONEUM; RATS; RATS, WISTAR; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA1;

EID: 56749132083     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn369     Document Type: Article

References (33)

1. Hung KY, Tsai TJ, Chen WY. Peritoneal fibrosis and its prevention. Nephrology 2002; 7: 227-232
2. Dobbie JW. Pathogenesis of peritoneal fibrosing syndrome (sclerosing peritonitis) in peritoneal dialysis. Perit Dial Int 1992; 12: 14-27
3. Renvall S, Lehto M, Penttinen R. Development of peritoneal fibrosis occurs under the mesothelial cell layer. J Surg Res 1987; 43: 407-412
4. Gotloib L, Waisbrut V, Shostak A et al. Acute and long-term changes observed in imprints of mouse mesothelium exposed to glucose-enriched, lactated, buffered dialysis solutions. Nephron 1995; 70: 466-477
5. Saed GM, Diamond MP. Effect of glucose on the expression of type I collagen and transforming growth factor-beta1 in cultured human peritoneal fibroblasts. Fertil Steril 2003; 79: 158-163
6. Jones S, Holmes CJ, Krediet RT et al. Bicarbonate/lactate-based peritoneal dialysis solution increases cancer antigen 125 and decreases hyaluronic acid levels. Kidney Int 2001; 59: 1529-1538
7. Lin CY, Chen WP, Yang LY et al. Persistent transforming growth factor-beta 1 expression may predict peritoneal fibrosis in CAPD patients with frequent peritonitis occurrence. Am J Nephrol 1998; 18: 513-519
8. Hung KY, Chen CT, Huang JW et al. Dipyridamole inhibits TGF-β-induced collagen gene expression in human peritoneal mesothelial cells. Kidney Int 2001; 60: 1249-1257
9. Medcalf JF, Walls J, Pawluczyk IZ et al. Effects of glucose dialysate on extracellular matrix production by human peritoneal mesothelial cells (HPMC): the role of TGF-beta. Nephrol Dial Transplant 2001; 16: 1885-1892
10. Ha H, Yu MR, Lee HB. High glucose-induced PKC activation mediates TGF-beta 1 and fibronectin synthesis by peritoneal mesothelial cells. Kidney Int 2001; 59: 463-470
11. Chen YM, Chien CT, Hu-Tsai MI et al. Pentoxifylline attenuates experimental mesangial proliferative glomerulomephritis. Kidney Int 1999; 56: 932-943
12. Hung KY, Huang JW, Chen CT et al. Pentoxifylline modulates intracellular signaling of TGF-b in cultured human peritoneal mesothelial cells: implications for prevention of encapsulating peritoneal sclerosis. Nephrol Dial Transplant 2003; 18: 670-676
13. Hung KY, Chen CT, Yen CJ et al. Dipyridamole inhibits PDGF-stimulated human peritoneal mesothelial cell proliferation. Kidney Int 2001; 60: 872-881
14. Xu SG, Kim KS, Park HC et al. High glucose activates the p38 MAPK in cultured human peritoneal mesothelial cells. Kidney Int 2003; 63: 958-968
15. Fujita H, Omori S, Ishikura K et al. ERK and p38 mediate high glucose-induced hypertrophy and TGF-beta expression in renal tubular cells. Am J Physiol Renal Physiol 2004; 286: F120-F126
16. Hung KY, Wu KD, Tsai TJ. In vitro study of peritoneal fibrosis. Perit Dial Int 2007; 27: S72-S75
17. Lin SL, Chen RH, Chen YM et al. Pentoxifylline attenuates tubulointerstitial fibrosis by blocking Smad3/4-activated transcription and profibrogenic effects of connective tissue growth factor. J Am Soc Nephrol 2005; 16: 2702-2713
18. Hung KY, Shyu RS, Fang CC et al. Dipyridamole inhibits human peritoneal mesothelial cell proliferation in vitro and attenuates rat peritoneal fibrosis in vivo. Kidney Int 2001; 59: 2316-2324
19. Hekking LH, Zareie M, Driesprong BA et al. Better preservation of peritoneal morphologic features and defense in rats after long-term exposure to a bicarbonate/lactate-buffered solution. J Am Soc Nephrol 2001; 12: 2775-2786
20. Gorelik L, Flavell RA. Transforming growth factor-beta in T-cell biology. Nat Rev Immunol 2002; 2: 46-53
21. Sakamoto N, Sugimura K, Kawashima H et al. Influence of glucose and inflammatory cytokines on TGF-beta1 and CTGF mRNA expressions in human peritoneal mesothelial cells. Int J Mol Med 2005; 15: 907-911
22. Zweers MM, de Waart DR, Smit W et al. Growth factors VEGF and TGF-beta1 in peritoneal dialysis. J Lab Clin Med 1999; 134: 124-132
23. Chen Y, Blom IE, Sa S et al. CTGF expression in mesangial cells: involvement of SMADs, MAP kinase, and PKC. Kidney Int 2002; 62: 1149-1159
24. Cooker LA, Luneburg P, Holmes CJ et al. (Bicarbonate/Lactate Study Group). Interleukin-6 levels decrease in effluent from patients dialyzed with bicarbonate/lactate-based peritoneal dialysis solutions. Perit Dial Int 2001; 21(Suppl 3): S102-S107
25. Matsuo H, Tamura M, Kabashima N et al. Prednisolone inhibits hyperosmolarity-induced expression of MCP-1 via NF-kappaB in peritoneal mesothelial cells. Kidney Int 2006; 69: 736-746
26. Lee SK, Kim BS, Yang WS et al. High glucose induces MCP-1 expression partly via tyrosine kinase-AP-1 pathway in peritoneal mesothelial cells. Kidney Int 2001; 60: 55-64
27. Imai H, Nakamoto H, Fukushima R et al. Role of adhesion molecules in the progression of peritoneal sclerosis. Adv Perit Dial 2003; 19: 180-185
28. Williams JD, Craig KJ, von Ruhland C et al. (Biopsy Registry Study Group). The natural course of peritoneal membrane biology during peritoneal dialysis. Kidney Int 2003; 64(Suppl 88): S43-S49
29. Devuyst O, Topley N, Williams JD. Morphological and functional changes in the dialysed peritoneal cavity: impact of more biocompatible solutions. Nephrol Dial Transplant 2002; 17(Suppl 3): 12-15
30. Breborowicz A, Pawlaczyk K, Polubinska A et al. Effect of peritoneal dialysis on renal morphology and function. Nephrol Dial Transplant 2006; 21: 3539-3544
31. Hung KY, Shyu RS, Huang JW et al. Natural changes in peritoneal equilibrium test results in CAPD patients: a retrospective, seven-year cohort survey. Artif Organs 2000; 24: 261-264
32. Hung KY, Lin TJ, Tsai TJ et al. Impact of peritoneal membrane transport on technique failure and patient survival in a population on automated peritoneal dialysis. ASAIO J 1999; 45: 568-573
33. Churchill DN, Thorpe KE, Nolph KD et al. (the Canada-USA (CANUSA) Peritoneal Dialysis Study Group). Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. J Am Soc Nephrol 1998; 9: 1285-1292